医療用インプラントの世界市場 - 予測（2023年～2028年）

世界の医療用インプラント市場は、慢性疾患の増加や高齢化の進行により、今後数年間で急成長すると予測されています。

当レポートでは、世界の医療用インプラント市場について調査分析し、市場力学、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
• 業界バリューチェーン分析

第5章 医療用インプラント市場の分析：タイプ別

• イントロダクション
• 整形外科
• 心血管
• 脊髄
• 眼科
• 歯科
• 顔
• その他

第6章 医療用インプラント市場の分析：材料別

• イントロダクション
• 金属、合金
• セラミック
• ポリマー
• 天然

第7章 医療用インプラント市場の分析：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • その他
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • インドネシア
  • タイ
  • その他

第8章 競合環境と分析

• 主な企業と戦略の分析
• 新興企業と市場の収益性
• 合併・買収・合意・提携
• ベンダーの競争力マトリックス

第9章 企業プロファイル

• Johnson & Johnson Services, Inc.
• Abbott Laboratories
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Conmed Corporation
• Globus Medical, Inc.
• Integra Lifesciences Holdings Corporation
• Smith & Nephew PLC
• Stryker Corporation
• Zimmer Biomet

Medical implants are efficient in enhancing the existing biological structure while replacing the damaged one. Screws, orthopedic rods, and pins are examples of implantable devices which are efficiently used in repairing artificial hip joints to replace the hip bones that are worn by arthritis, and fractured bones among others. Medical implants are imperatively used in areas such as orthopedic, cardiovascular, neurological, and even dental ailments. It is also important to note that these implants are made up of bones, skin tissues, and even from skin whereas there are implants that are made up of plastic or ceramic materials including metal. These implants can be used permanently as well as they can be removed when they are no longer required. The increasing number of road accidents followed by the growing geriatric population are a few factors that are driving the demand for the medical implants market worldwide. Moreover, the presence of chronic disease is further fuelling the demand for this market. Further, the increasing awareness about the use of medical plants along with the benefits they offer will furthermore create a demand for these in the market amongst healthcare professionals.

The medical implant market is expected to surge in the coming years due to the rise in chronic diseases and the increasing aging population.

The immunity levels start to decrease as individuals grow out of their age which makes them susceptible to multiple diseases and problems. These diseases can vary from cardiovascular ones, orthopedic problems due to weakness in the bones, dental disorders, and many more. In this regard, the medical implant market in the increasingly aged population plays an imperative role. Further, tooth loss is the most common issue which is found with the increasing aging population and this particular factor is expected to drive the market growth of the medical implant market. For instance, according to the American Academy of Implant Dentistry (AAID), the United States is said to consist of about 3 million individuals who are currently having dental implants and in recent times, this number is expected to grow tremendously by 500,000 annually.

Market Developments

• In March 2022, Bredent Medical's whiteSKY ceramic implant system added a new one-piece whiteSky Tissue Line, which is adaptable and appropriate for a variety of indications, including single restorations in the aesthetic zone and short-span bridges in the premolar and molar area.
• In April 2022, Neodent, a well-known provider of dental implants in Brazil and a member of the Straumann Group, unveiled a brand-new implant system. The brand-new item, called Zi, is made of zirconia, which is renowned for its exceptional strength and beauty. Zi's global premiere was commemorated at a virtual event that drew 1,600 viewers from 92 different nations.
• ZimVie Inc, in June 2022, announced that the FDA (Food and Drug Administration) of the US had cleared the T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the country, which was the latest addition to ZimVie's product portfolio of dental implants and was an upgrade to the T3 Tapered Implant.
• In February 2022, DeGen Medical, Inc., which is a form dealing with spinal implants and specializing in augmented reality, launched the Impulse AM, which is a 3D-printed porous titanium implant for posterior interbody fusion.

By materials, the medical implants market is segmented into metals and alloys, ceramics, polymers, and natural. Ceramics as a biomaterial in the medical implants market will witness a rise in demand during the forecast period. Ceramics are incredibly durable and can withstand intense pressure, nuclear radiation, highly corrosive chemicals, and high temperatures. The above factors mentioned of ceramic material make them the perfect choice for a wide range of medical implant applications, including implanted electrical sensors, stimulators, and drug delivery systems.

Regional Insights

Based on geography, the medical implants market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. The North American region is estimated to hold a significant market share due to the advanced medical and healthcare facilities in the region along with the relatively high disposable income of the people. According to data by the Centres for Disease Control and Prevention in 2021, about 1 in 5 people aged 65 and above in the US had complete tooth loss. Segmenting it further, 13% of seniors aged from 65 to 74 and 26% of seniors aged 75 and above had undergone complete tooth loss. Tooth decay is a cause of this in multiple cases. Further, according to data from the American Dental Association in 2020, 91% of adults in the US aged between 20 and 65 have dental cavities, and about 27% of people were reported to not have undergone any treatment for the same.

Market Segmentation

By Type

• Orthopedic
• Cardiovascular
• Spinal
• Ophthalmic
• Dental
• Facial
• Others

By Material

• Metals And Alloys
• Ceramic
• Polymers
• Natural

By Geography

• North America
  • United States
  • Canada
  • Mexico

• South America
  • Brazil
  • Argentina
  • Others

• Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others

• The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others

• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Definition
• 1.2. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. MEDICAL IMPLANTS MARKET ANALYSIS, BY TYPE

• 5.1. Introduction
• 5.2. Orthopedic
• 5.3. Cardiovascular
• 5.4. Spinal
• 5.5. Ophthalmic
• 5.6. Dental
• 5.7. Facial
• 5.8. Others

6. MEDICAL IMPLANTS MARKET ANALYSIS, BY MATERIAL

• 6.1. Introduction
• 6.2. Metals And Alloys
• 6.3. Ceramic
• 6.4. Polymers
• 6.5. Natural

7. MEDICAL IMPLANTS MARKET ANALYSIS, BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. United States
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. United Kingdom
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. The Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Israel
  • 7.5.4. Others
• 7.6. Asia Pacific
  • 7.6.1. Japan
  • 7.6.2. China
  • 7.6.3. India
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1 Major Players and Strategy Analysis
• 8.2 Emerging Players and Market Lucrativeness
• 8.3 Mergers, Acquisitions, Agreements, and Collaborations
• 8.4 Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1 Johnson & Johnson Services, Inc.
• 9.2 Abbott Laboratories
• 9.3 Boston Scientific Corporation
• 9.4 Cardinal Health, Inc.
• 9.5 Conmed Corporation
• 9.6 Globus Medical, Inc.
• 9.7 Integra Lifesciences Holdings Corporation
• 9.8 Smith & Nephew PLC
• 9.9 Stryker Corporation
• 9.10 Zimmer Biomet